[1] Nestle FO, Turka LA, Nickoloff BJ.Characterization of dermal dendritic cells in psoriasis.Autostimulation of T lymphocytes and induction of Th1 type cytokines.J Clin Invest, 1994,94:202-209. [2] Dam TN, Moller B, Hindkjaer J, et al.The vitamin D3 analog calcipotriol suppresses the number and antigen-presenting function of Langerhans cells in normal human skin.J Investig Dermatol Symp Proc, 1996,1:72-77. [3] Zhu K, Mrowietz U.Inhibition of dendritic cell differentiation by fumaric acid esters.J Invest Dermatol, 2001,116:203-208. [4] Cooper KD, Baadsgaard O, Ellis CN, et al.Mechanisms of cyclosporin A inhibition of antigen-presenting activity in uninvolved and lesional psoriatic epidermis.J Invest Dermatol, 1990, 94:649-656. [5] Sallusto F, Lanzavecchia A.Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.J Exp Med, 1994,179:1109-1118. [6] Valdimarsson H, Sigmundsdottir H, Jonsdottir I.Is psoriasis induced by streptococcal superantigens and maintained by M-protein-specific T cells that cross-react with keratin? Clin Exp Immunol, 1997,107(Suppl 1):21-24. [7] Drakesmith H, Chain B, Beverley P.How can dendritic cells cause autoimmune disease? Immunol Today, 2000,21:214-217. [8] Geissmann F, Prost C, Monnet JP, et al.Transforming growth factor beta 1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells.J Exp Med, 1998,187:961-966. [9] Asadullah K, Sterry W, Stephanek K, et al.IL-10 is a key cytokine in psoriasis.Proof of principle by IL-10 therapy:a new therapeutic approach.J Clin Invest, 1998,101:783-794. |